Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Journal for Immunotherapy of Cancer
|
March 29, 2020
Cellular cytotoxicity is a form of immunogenic cell death
Luna Minute, Alvaro Teijeira, Alfonso R Sanchez-Paulete, et al.
Theranostics
|
February 14, 2022
Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers
Alvaro Teijeira, Itziar Migueliz, Saray Garasa, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2022
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
Javier Glez-Vaz, Arantza Azpilikueta, Irene Olivera, et al.
Oncoimmunology
|
April 10, 2023
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic
Maite Alvarez, Carmen Molina, Saray Garasa, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2019
Immunotherapeutic effects of intratumoral nanoplexed poly I:C
M Angela Aznar, Lourdes Planelles, Mercedes Perez-Olivares, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2023
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control
Maria E Rodriguez-Ruiz, Irantzu Serrano-Mendioroz, Eneko Garate-Soraluze, et al.
Oncoimmunology
|
November 21, 2015
Functional expression of CD137 (4-1BB) on T helper follicular cells
Carlos Alfaro, Jose I Echeveste, Maria E Rodriguez-Ruiz, et al.
Journal for Immunotherapy of Cancer
|
October 1, 2018
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis
Javier Rodriguez, Eduardo Castañón, Jose Luis Perez-Gracia, et al.
Journal for Immunotherapy of Cancer
|
November 26, 2021
Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy
Maite Alvarez, Carmen Molina, Carlos E De Andrea, et al.
Cancer Research
|
June 27, 2015
Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice
Miguel F Sanmamed, Inmaculada Rodriguez, Kurt A Schalper, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Journal for Immunotherapy of Cancer
|
March 29, 2020
Cellular cytotoxicity is a form of immunogenic cell death
Luna Minute, Alvaro Teijeira, Alfonso R Sanchez-Paulete, et al.
Theranostics
|
February 14, 2022
Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers
Alvaro Teijeira, Itziar Migueliz, Saray Garasa, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2022
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
Javier Glez-Vaz, Arantza Azpilikueta, Irene Olivera, et al.
Oncoimmunology
|
April 10, 2023
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic
Maite Alvarez, Carmen Molina, Saray Garasa, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2019
Immunotherapeutic effects of intratumoral nanoplexed poly I:C
M Angela Aznar, Lourdes Planelles, Mercedes Perez-Olivares, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2023
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control
Maria E Rodriguez-Ruiz, Irantzu Serrano-Mendioroz, Eneko Garate-Soraluze, et al.
Oncoimmunology
|
November 21, 2015
Functional expression of CD137 (4-1BB) on T helper follicular cells
Carlos Alfaro, Jose I Echeveste, Maria E Rodriguez-Ruiz, et al.
Journal for Immunotherapy of Cancer
|
October 1, 2018
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis
Javier Rodriguez, Eduardo Castañón, Jose Luis Perez-Gracia, et al.
Journal for Immunotherapy of Cancer
|
November 26, 2021
Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy
Maite Alvarez, Carmen Molina, Carlos E De Andrea, et al.
Cancer Research
|
June 27, 2015
Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice
Miguel F Sanmamed, Inmaculada Rodriguez, Kurt A Schalper, et al.
Page
of 8